Idiopathic Osteonecrosis Research Articles

Background & objectives:Primary or idiopathic osteonecrosis of femur head (ONFH) is the second most commonly observed cause among Indian patients suffering from ischemic ONFH. Although a number of genetic polymorphisms have been associated with idiopathic ONFH pathogenesis in Korean and Chinese populations, there are no studies in the Indian population. This is an exploratory study designed to implicate in promoter sequence polymorphisms of a critical fibrinolytic system regulator, plasminogen activator inhibitor-1 (PAI-1) gene, in cases of idiopathic osteonecrosis. Promoter sequence variations can affect expression levels of PAI-1 gene and may disrupt the coagulation/fibrinolytic equilibrium, which may finally culminate into osteonecrosis. Hence, the aim of the study was to investigate the role of single-nucleotide polymorphisms (SNPs) in the promoter region of PAI-1 gene and osteonecrosis development.Methods:Two SNPs of the PAI-1 gene (rs2227631, -844 G/A; rs1799889, -675 4G/5G) were genotyped in 25 patients diagnosed with idiopathic ONFH and 25 control subjects, using direct sequencing. Subsequently, association analyses were performed for the genotyped SNPs.Results:Both the rs2227631 and rs1799889 genotype and allele frequencies of PAI-1 gene showed an insignificant association with osteonecrosis risk (P=0.717, 0.149). Haplotype frequencies of rs2227631 and rs1799889 were also calculated in patients having idiopathic ONFH and controls. Although the distribution of haplotype GA-4G 4G was found to be the highest among the cases, it was not significantly different when compared with the controls.Interpretation & conclusions:Our findings demonstrate that the minor alleles of promoter region sequences of the PAI-1 gene do not contribute to an increase in ONFH predisposition. However, this is a preliminary study and its findings should be considered as suggestive for studies to be done in a larger sample size.

A case of total talar replacement for idiopathic osteonecrosis of the talus

The Clinical Result of Transtrochanteric Curved Varus Osteotomy for Idiopathic Osteonecrosis of the Femoral Head

A case of total hip arthroplasty for idiopathic osteonecrosis of the femoral head caused by Takayasu arteritis

Background: Cushing's disease is an endocrine disorder and may be associated with non-traumatic osteonecrosis of the hip. We report the case of avascular necrosis of the femoral heads (AVNFH) as the presenting manifestation of Cushing's disease. Case presentation: A 29-year-old male patient was referred to our department because of non-traumatic bilateral hip pain evolving for two years. The pain was associated with lameness when walking. He noticed a drop in libido since one year with erectile dysfunction. Physical examination revealed facio-truncal obesity, abdominal violaceous striae, dorsal hyper-kyphosis, a pain and limitation of internal rotation of the left hip with a Lequesne index of 16. The standard radiography showed a loss of sphericity of the left femoral head with an aspect of eggshell. The MRI confirmed the diagnosis of a bilateral AVNFH. The baseline cortisol level was 287 ng/ml. AVNFH as the presenting manifestation of Cushing's disease was suspected and confirmed by a pituitary MRI which revealed a pituitary adenoma. A discharge of the hips was indicated. The patient underwent surgical resection of the adenoma and was referred to the endocrinology department. The histopathological examination confirmed the diagnosis of pituitary adenoma (corticotrope adenoma). The patient has also received an intravenous perfusion of 5 mg of Zoledronic acid. The follow up was marked by the regression of the symptoms of Cushing's disease and the hip pain. Conclusion: AVNFH as the presenting manifestation of Cushing's disease is rarely described. Hence, it’s needed to exclude endogenous hypercorticism in any patient with idiopathic osteonecrosis.

Association of Neutrophil Extracellular Traps with the Development of Idiopathic Osteonecrosis of the Femoral Head

Neck modularity was introduced to improve total hip arthroplasty (THA) accuracy, but it has been associated with early breakages and corrosion issues. In our hospital, modular necks have been in clinical use since the 1990s. We retrospectively analysed the occurrence of these sequelae in implants placed between January 2000 and December 2014. Survival data from patients operatedon in our hospital were obtained from the regional arthroplasty registry (Registro dell'Impiantologia Protesica Ortopedica, RIPO). The cohort comprised 928 THAs on 908 patients. The average patient age was 67.8years. Main indications were primary osteoarthritis (71.4%), fracture (9.2%), congenital dysplasia or congenital luxation (7.8%), and idiopathic osteonecrosis (6.4%). All femoral stems were cementless, with 318 anatomically shaped (34.3%), 579 straight (62.4%), and 31 short stems (3.3%). All necks used were made of titanium alloy. The average follow-up time was 9.6years (range, 4-18years). In total, 66 revisions were reported. The main revision causes were periprosthetic fractures (33.3%), aseptic stem loosening (19.7%), luxation (18.2%), and implant breakage (12.1%). Five modular neck breakages were recorded. The overall survival rate was 87.7% at 17years. We did not observe any component corrosion. The neck breakage rate was 0.5%, and the luxation rate was 1.3%. Our experience suggests that neck modularity is a safe, effective way to reconstruct the proximal femur in THA patients. We attribute the absence of corrosion to the exclusive use of titanium necks.

Core decompression is a surgical option since the 1960s for hip osteonecrosis treatment. This technique promotes bone repair by reducing intramedullary pressure, but this is not often enough to stop the progression of necrosis. The aim of this study was to associate core decompression with the regenerative stimulus provided by platelet-rich plasma (PRP) and compare our results with other regenerative techniques. Femoral head osteonecrosis was prospectively evaluated in 30 hips (22 patients, 15-60years) treated by core decompression and PRP graft. Patients presented monolateral or bilateral osteonecrosis in stage I-IIA-IIB according to Arlet and Ficat classification. The outcome was assessed by changes in Harris Hip Score (HHS) and the need for total hip replacement (THA). The mean preoperative HHS was 64 points, at two years from surgery was roughly 84 points. Sixteen of 30 hips showed osteonecrosis progression of the femoral head and were converted to THA. At the fiveyear follow-up, the survival rate was 100% for patients at stage I, 67% for stage IIA, and 0% for stage IIB and was 68% and 32% for idiopathic and secondary osteonecrosis, respectively. Core decompression combined with PRP could be indicated as a treatment for the I and IIA stages of osteonecrosis, as it significantly reduces joint pain and delays THA. This procedure should be avoided in AVNFH related to cortisone therapy because only a few benefits have been proven. It also has the advantage of being technically simple, minimally invasive, and free from complications.

ObjectiveTo compare the intraoperative, radiological, and clinical short‐term outcomes of cementless total hip arthroplasties (THA) using a short stem (SS) and a conventional femoral stem (CS) in a randomized prospective control study.MethodsFrom June 2011 to October 2017, patients who underwent cementless THA for idiopathic osteonecrosis of the femoral head were recruited. Patients had a minimum 2 years of follow‐up after the operation. The patients were divided into two groups: those who underwent THA using an SS and those who underwent THA using a CS. SS were used in 34 patients (41 hips) and CS were used in 41 patients (45 hips). In both groups, the same cup was used in all cases, and the mean follow‐up periods were 63 (26–101) months in the SS and 64 (26–101) months in the CS groups. Intraoperative, clinical, and radiological evaluations were performed for the two groups.ResultsThere was no difference in the demographics of the two groups. There was one patient with a proximal femoral crack in the SS group and one with a distal femoral crack in the CS group. Clinically, the mean Harris hip score was improved in both groups at 2‐year follow‐up. Radiographically endosteal osseointegrations were found in 40 of 41 cases in the SS group and in 44 of 45 cases in the CS group. There was one case of dislocation in each group. In the SS group, the acetabular cup was changed and repositioned 7 months after the initial operation. Stem loosening, infection, ceramic breakage, and varus/valgus change were not observed. There was a statistically significant lower stress shielding effect in the SS group. There were no differences in vertical/parallel offset and leg length discrepancy.ConclusionThe intraoperative, radiological, and clinical evaluations in both groups showed good outcomes and there was no statistically significant difference between the two groups.

Urinary miRNAs as biomarkers for idiopathic osteonecrosis of femoral head: A multicentre study

Acetabular Anatomical Parameters in Patients With Idiopathic Osteonecrosis of the Femoral Head

Ultra-Short Anatomic Uncemented Femoral Stem and Ceramic-on-Ceramic Bearing in Patients With Idiopathic or Ethanol-Induced Femoral Head Osteonecrosis

To the Editor: I read with great interest the recent report of Yang et al[1], “Clinical Characteristics and Treatment of Spontaneous Osteonecrosis of Medial Tibial Plateau: A retrospective case study” (published on November 5, 2018, Chin Med J, page 2544–2550), because there have been very few reports on isolated spontaneous medial tibial plateau osteonecrosis and little is known about osteonecrosis of the tibial plateau. I would like to comment on diagnostic issues in this letter. Osteonecrosis of the knee can be a devastating disease that leads to end-stage arthritis of the knee. The knee is the second most commonly affected site after the hip.[2] Spontaneous osteonecrosis of the knee (SPONK) involving medial femoral condyle was described as a distinct entity by Ahlback et al in 1968[3] and is also called idiopathic or primary osteonecrosis to distinguish it from secondary osteonecrosis, which is associated with corticosteroid therapy, blood dyscrasias, Gaucher disease, caisson disease,[4] and other rare conditions, for example, laser-assisted arthroscopic chondroplasty.[5] The condition usually involves a single condyle, most often the medial femoral condyle, affected in 94% of the cases and can also occur in the lateral femoral condyle or in the tibial plateaus.[6] Involvement of the tibial plateau, which was first reported in the French literature by d’Angelijan et al[7] in 1967 and was described in the English literature by Houpt et al[8] is less common. Only 2% of osteonecrosis around the knee may affect the tibial plateau. The medial tibial plateau is more frequently affected than the lateral.[9] Therefore, to our knowledge, it remains a rare cause of knee pain. In the article, the case group contains 22 patients in 15 months (from March 2015 to June 2016), it means real prevalence may be underestimated. Magnetic resonance imaging (MRI) is both sensitive and specific for recognizing SPONK of both medial femoral condyle and tibial plateau and recommended for detection of the disease, due to its high sensitivity in detecting bone marrow edema.[10] MRI characteristics include a diffuse area of hyperintensity widespread into the metaphysics on T2-weighted images, the focal subchondral area of low signal intensity adjacent to the subchondral bone plate on T1-weighted images and focal epiphyseal contour depressions. But the MRI-detected subchondral bone marrow lesion, comprised of fibrosis, necrosis, edema, and bleeding into fatty marrow in different proportions as well as abnormal trabeculae, is also a common finding in patients with OA.[11] In the article, the MRI images showed in Figures 2 and 5 have no typical MRI signs of spontaneous medial tibial plateau osteonecrosis, MRI T1 and T2 images show cartilage degeneration, narrow of joint space, focal bone marrow edema and formation of subchondral cysts in medial knee compartment. We think it is more likely anteromedial osteoarthritis of knee, not a typical SPONK of medial tibial plateau. Although medial unicompartmental knee arthroplasty is also appropriate surgical indication. We also noted that in the series, there are 17 patients (77%) with a Level III medial meniscus posterior root tears (MMPRT) and the lesions of 68% patients involved the central tibial plateau. Subchondral marrow edema deep to the MMPRT was described as a harbinger of meniscal root failure. Ipsilateral tibiofemoral compartment bone marrow edema and insufficiency fractures are commonly noted in the presence of posterior meniscal tears.[12] Therefore, differential diagnosis is important and the condition has not been clearly discussed. Funding This work was supported by a grant from Ministry of Science and Technology of China (No. 2017YFC0108003). Conflicts of interest None.

Idiopathic osteonecrosis of the mandible in a 49 healthy male patient: a rare and interesting case report

A pilot study -role of DSA in assessing vascularity of proximal femur in idiopathic femoral head osteonecrosis

BackgroundPerthes’ disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of different interventions challenging. This study aims to summarise the outcomes used in clinical research of interventions for Perthes’ disease and define a set of core outcomes (COS) to ensure that the variables of primary importance are measured and reported in future research studies investigating Perthes’ disease.MethodsA systematic review of the current literature will be used to identify a list of outcomes reported in previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes’ disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then be evaluated by experts in Perthes’ disease using a Delphi survey divided into two rounds to ascertain the importance of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials related to Perthes’ disease.DiscussionThe absence of high-quality research and clear guidelines concerning the management of Perthes’ disease is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made and to facilitate meta-analyses of results.Trial registrationCore Outcome Measures in Effectiveness Trials Initiative (COMET), 1003. Registered on 20 July 2017. Prospero International Prospective Register of Systematic Reviews, CRD 42017069742. Registered on 10 July 2017.

ObjectivesLegg–Calvé–Perthes’ disease (LCP) is an idiopathic osteonecrosis of the femoral head that is most common in children between four and eight years old. The factors that lead to the onset of LCP are still unclear; however, it is believed that interruption of the blood supply to the developing epiphysis is an important factor in the development of the condition.MethodsFinite element analysis modelling of the blood supply to the juvenile epiphysis was investigated to understand under which circumstances the blood vessels supplying the femoral epiphysis could become obstructed. The identification of these conditions is likely to be important in understanding the biomechanics of LCP.ResultsThe results support the hypothesis that vascular obstruction to the epiphysis may arise when there is delayed ossification and when articular cartilage has reduced stiffness under compression.ConclusionThe findings support the theory of vascular occlusion as being important in the pathophysiology of Perthes disease.Cite this article: M. Pinheiro, C. A. Dobson, D. Perry, M. J. Fagan. New insights into the biomechanics of Legg-Calvé-Perthes’ disease: The Role of Epiphyseal Skeletal Immaturity in Vascular Obstruction. Bone Joint Res 2018;7:148–156. DOI: 10.1302/2046-3758.72.BJR-2017-0191.R1.

Idiopathic osteonecrosis of the femoral head (IONFH) is an ischemic disorder that causes bone necrosis of the femoral head, resulting in hip joint dysfunction. IONFH is a polygenic disease and steroid and alcohol have already known to increase its risk; however, the mechanism of IONFH remains to be elucidated. We performed a genome-wide association study using ~60,000 subjects and found two novel loci on chromosome 20q12 and 12q24. Big data analyses identified LINC01370 as a candidate susceptibility gene in the 20q12 locus. Stratified analysis by IONFH risk factors suggested that the 12q24 locus was associated with IONFH through drinking capacity. Our findings would shed new light on pathophysiology of IONFH.

特発性脛骨内顆・外顆骨壊死に対してopening-wedge高位脛骨骨切り術を行った1例

To identify the predictive risk factors of total hip arthroplasty (THA) conversion after concentrated autologous bone marrow aspirate transplantation (CABMAT) as a hip joint–preserving surgery for idiopathic osteonecrosis of the femoral head (ONFH). We retrospectively reviewed 123 patients (213 hips; 65 men [115 hips]) who underwent CABMAT (average age: 40 years) between April 2003 and December 2010. The mean follow-up period was 61 months. Of 213 hips, 144 had corticosteroid-associated ONFH, 46 had alcohol-associated ONFH, and 23 had no identifiable etiological factors. We investigated age; sex; body mass index (BMI); history of using bisphosphonates, steroids, and proton pump inhibitors; etiologic factors; preoperative disease classification and staging; Japanese Orthopedic Association clinical score; and various clinical data. Multivariate logistic regression analysis was performed to analyze the data. Of 213 hips, 51 (23.9%) were converted to THA. The conversion rates were 18.6% in the precollapse group (stages 1 and 2) and 30.0% in the postcollapse group (stages 3–4). The conversion rate to THA was 0% in patients with the preoperative disease types A and B. Moreover, treatment in 62.5% of patients in stage 4 was converted to THA. In multivariate logistic regression analysis, the disease type, BMI, history of bisphosphonates use, hospitalization duration, and age were significantly correlated with conversion to THA. The largest THA conversion predictive factor was the type C2. The preoperative disease type, BMI, and history of bisphosphonates use can predict conversion to THA and suggest which patients with idiopathic ONFH are appropriate for CABMAT treatment. Our new marrow concentration method for CABMAT improves the reliability of hip preserving surgery, and further research is warranted.